XOMA prolongs tender offer for LAVA Therapeutics until October 17
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 02 2025
0mins
Source: SeekingAlpha
Tender Offer Extension: XOMA Royalty and LAVA Therapeutics have extended the tender offer expiration to October 17, 2025, at 11:59 p.m. ET.
Acquisition Details: The offer includes a cash payment and a non-transferable contingent value right (CVR) for 75% of net proceeds from partnered assets and any out-licensed or sold unpartnered programs, with the acquisition expected to close in Q4 2025.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
